Targeting Endothelial Cells with Heme Oxygenase-1 Gene Using VE-Cadherin Promoter Attenuates Hyperglycemia-Mediated Cell Injury and Apoptosis
- 1 December 2007
- journal article
- research article
- Published by Mary Ann Liebert Inc in Antioxidants and Redox Signaling
- Vol. 9 (12), 2065-2074
- https://doi.org/10.1089/ars.2007.1804
Abstract
Risk factors for cardiovascular diseases include hyperglycemia, TNF, and reactive oxygen species (ROS), which collectively contribute to vascular endothelial cell dysfunction and apoptosis. We examined, in vascular endothelial cells, whether the selective expression of heme oxygenase-1 (HO-1) offers cytoprotection against glucose- and TNF-mediated cell death. An adenoviral vector expressing human HO-1 was constructed using a VE-cadherin (VECAD) promotor fragment, and cell-specific expression of the recombinant adenovirus was examined using endothelial and vascular smooth muscle cells. The effects of HO-1 transduction (Ad-VECAD-HO-1 gene) on HO-1 expression, HO activity, and the response to TNF and hyperglycemia were studied. Human HO-1 gene was selectively expressed in endothelial cells after infection with the Ad-VECAD-HO-1 vector. Selective expression of HO-1 prevented TNF- and hyperglycemia-mediated superoxide (O2-) formation, DNA degeneration, and upregulation of caspase, but increased the expression of pAkt and Bcl-xL, proteins responsible for endothelial dysfunction in diabetes. These results demonstrate that endothelial cell survival after oxidative stress injury may be enhanced by targeting HO-1 expression, thus blocking inflammation, apoptosis, and thereby attenuating cardiovascular risk factors.Keywords
This publication has 55 references indexed in Scilit:
- Heme Oxygenase-1 Enhances Renal Mitochondrial Transport Carriers and Cytochrome c Oxidase Activity in Experimental DiabetesOnline Journal of Public Health Informatics, 2006
- Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end productsCardiovascular Diabetology, 2006
- Heme oxygenase and the cardiovascular–renal systemFree Radical Biology & Medicine, 2005
- Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Endothelial DysfunctionJournal of the American Society of Nephrology, 2004
- Heme Oxygenase-1 Attenuates Glucose-Mediated Cell Growth Arrest and Apoptosis in Human Microvessel Endothelial CellsCirculation Research, 2003
- Carbon Monoxide Generated by Heme Oxygenase 1 Suppresses Endothelial Cell ApoptosisThe Journal of Experimental Medicine, 2000
- A simple method for the rapid generation of recombinant adenovirus vectorsGene Therapy, 2000
- Negative Regulation of Human Heme Oxygenase in Microvessel Endothelial Cells by DexamethasoneProceedings of the Society for Experimental Biology and Medicine, 1999
- High-glucose--triggered apoptosis in cultured endothelial cellsDiabetes, 1995